Press Releases and Blog
Blog
Plus, An Important Policy on Interchangeability Big Pharma has a lot of tricks to drive higher profits. The Trump Administration isn’t fooled. PCMA applauds the Trump administration’s 2027 budget request that includes giving the Food and Drug Administration (FDA) more authority to crack down on direct-to-consumer (DTC) drug advertising. Pharmaceutical manufacturers spent nearly $14 billion on […]
PBM Reform is Law – DOL Should Withdraw Its Duplicative Proposal The Department of Labor’s proposed rule on “Improving Transparency into Pharmacy Benefit Manager Fee Disclosure” comes at a time when Congress has just taken significant action in this space. In recently submitted comments, PCMA explains why the Department should withdraw the proposal and reassess its […]
As lawmakers explore solutions to lower prescription drug costs for American families, attention is increasingly turning to how Big Pharma’s patent abuse keeps patients paying more and waiting longer for lower-cost medicines. A federal judge ruled this week that a brand drugmaker must face a lawsuit “claiming it used unlawful methods to block generic competition for its multiple sclerosis drug Copaxone.” USA […]
Today, the Senate HELP Committee is holding a hearing on using competition to lower drug prices. In a statement submitted to the committee, PCMA urges Congress to consider three actions to lower drug prices and help patients, pharmacies, and employers: Stop drug manufacturers from using anticompetitive practices like patent thickets to block generic drug competition. […]
Pharmacy benefit managers (PBMs) could not do their job without independent pharmacies. A strong, broad network of pharmacies is critical to patient access, and for millions of Americans an independent pharmacy is their closest touchpoint to the health care system. That’s why PBMs actively support independent pharmacists with higher reimbursements, while helping patients safely access […]
Small businesses are vital to the American economy and represent over 40% of the country’s GDP. They also face different health care challenges than bigger companies. The services that pharmacy benefit managers (PBMs) provide help make offering drug coverage for their workers possible. And a national survey shows that small businesses are highly satisfied with […]
Press Releases
Today, the Pharmaceutical Care Management Association (PCMA) submitted formal comments to the Department of Labor (DOL) as part of the rulemaking process for the proposed regulation, “Improving Transparency into Pharmacy Benefit Manager Fee Disclosure.” PCMA called on DOL to rescind the proposed rule because it is unnecessary and risks degrading a competitive and effective PBM industry. Specifically: The proposal is blatantly redundant of the recently passed PBM reform legislation signed into law by President Trump, The proposal offers nearly no additional meaningful transparency for employers, and The proposal threatens to reduce competition in the PBM market. On releasing PCMA’s comment letter, David Marin, President […]
(WASHINGTON, D.C.) – Yesterday, a federal court ruled in favor of McKee Foods, a privately held and family-owned employer based in Tennessee, finding that a 2023 law there regulating pharmacy benefit managers (PBMs) and their client health plans and sponsors is preempted by federal law. The ruling by the Sixth Circuit mirrors the Tenth Circuit’s […]
Strong Satisfaction with Cost Savings, Transparency, and Coverage Offerings All Benefit Patients (Washington, D.C.) — Employers who provide drug coverage for their workers throughout the country report high satisfaction with how pharmacy benefit managers (PBMs) reduce drug costs, offer coverage options to fit their businesses, and provide transparency to show how and where their businesses fund […]
(Washington, D.C) – A new report confirms that pharmacy benefit managers (PBMs) quickly promote patient access to new, affordable generic drugs over high-priced brand-name drugs. The study, conducted by Wakely Consulting Group, finds that in the first six months after a brand name drug’s patent expires, generic drugs can cover as much as 80% of the market as patients quickly transition to the […]
(Washington, D.C.) – Today, the Pharmaceutical Care Management Association, representing America’s pharmacy benefit managers (PBMs), is calling on the Department of Labor (DOL) to rescind its proposed rule “Improving Transparency into Pharmacy Benefit Manager Fee Disclosure,” which layers excessive, costly, and unnecessarily duplicative disclosure requirements on PBMs after President Trump just signed into law separate transparency requirements. This year, in […]
PBMs are transparent and reduce drug costs in New Jersey
The Pharmaceutical Care Management Association (PCMA) issued the following statement on New Jersey Governor Mikie Sherrill’s budget address: “The governor’s remarks today about pharmacy benefit managers (PBMs) are simply untrue and misleading to New Jersey patients, and it is imperative to correct the record. The mission of PBMs is to reduce prescription drug costs, and […]
